---
title: "RNA.US (RNA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RNA.US/news.md"
symbol: "RNA.US"
name: "RNA.US"
parent: "https://longbridge.com/en/quote/RNA.US.md"
datetime: "2026-05-21T03:16:49.850Z"
locales:
  - [en](https://longbridge.com/en/quote/RNA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RNA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RNA.US/news.md)
---

# RNA.US (RNA.US) — Related News

### [Atrium Therapeutics reported a net loss of $16.6 million in Q1, with milestone payments from BMS supporting revenue](https://longbridge.com/en/news/286589704.md)
*2026-05-15T15:43:13.000Z*
> Atrium Therapeutics announced its Q1 2026 financial report, with a net loss of $16.63 million and a loss per share of $0

### [Atrium Therapeutics Reports First Quarter 2026 Financial Results | RNA Stock News](https://longbridge.com/en/news/286465472.md)
*2026-05-14T12:40:26.000Z*
> Atrium Therapeutics Reports First Quarter 2026 Financial Results | RNA Stock News

### [11:44 ETAdvaita Bio představuje iSCanGuide™: Integrovanou analýzu jednobuněčné a prostorové transkriptomiky využívající infrastrukturu s GPU akcelerací](https://longbridge.com/en/news/285750410.md)
*2026-05-08T15:45:38.000Z*
> Advaita Bio has launched the iSCanGuide™, a cloud platform that integrates single-cell and spatial transcriptomics analy

### [Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Month](https://longbridge.com/en/news/283484751.md)
*2026-04-21T10:26:07.000Z*
> The health care sector's oversold stocks present buying opportunities, with Kiniksa Pharmaceuticals (KNSA), Nano-X Imagi